Key facts
- Puresport’s last known valuation is $11.5M (Feb 2025).
- It has raised $7.1M; the latest was Later Stage VC ($4.5M) in Feb 2025.
- Notable investors include Five Seasons Ventures, Alex Stewart, Bell Partnership, Brad MacCulloch, Cleavemoor — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Puresport
- ·The full record, as it builds
Funding rounds
No funding rounds for Puresport are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Puresport
Operator of a cannabidiol product brand intended to offer natural products to assist in injury recovery, easing anxiety, and promoting sleep. The company's products go through a rigid testing protocol that involves two separate third-party companies testing each batch of product and are tested by advanced cannabinoid testing kits, enabling athletes and professionals to get genuine products that deliver effective results.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2018
- Employees
- 48
- Website
- puresport.co/
- Ownership
- Privately Held (backing)
Puresport doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Puresport shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Puresport in its N-PORT filings yet. We sweep new filings monthly.